WHO statement on hormonal contraception and bone health.
d'Arcangues
Catherine
C
Department of Reproductive Health and Research, World Health Organization, CH-1211-Geneva-27, Switzerland. darcanguesc@who.int
D000293:Adolescent; D000328:Adult; D015519:Bone Density / Q000187:drug effects*; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects; D008875:Middle Aged; D045167:Progesterone Congeners / Q000009:adverse effects*; D014944:World Health Organization
D003271:Contraceptive Agents, Female; D003692:Delayed-Action Preparations; D045167:Progesterone Congeners; D017258:Medroxyprogesterone Acetate